King A - Search Results

1

Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: a twelve-year experience.

Baszis K, Garbutt J, Toib D, Mao J, King A, White A, French A. Baszis K, et al. Among authors: king a. Arthritis Rheum. 2011 Oct;63(10):3163-8. doi: 10.1002/art.30502. Arthritis Rheum. 2011. PMID: 21702011 Free article.

2

Radiation therapy for pilocytic astrocytomas of childhood.

Mansur DB, Rubin JB, Kidd EA, King AA, Hollander AS, Smyth MD, Limbrick DD, Park TS, Leonard JR. Mansur DB, et al. Among authors: king aa. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):829-34. doi: 10.1016/j.ijrobp.2009.11.015. Epub 2010 Apr 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 20421157

3

Reconsideration of age as a contraindication for curative therapy of sickle cell disease.

King AA, DiPersio JF. King AA, et al. JAMA. 2014 Jul 2;312(1):33-4. doi: 10.1001/jama.2014.7193. JAMA. 2014. PMID: 25058214 No abstract available.

4

Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database.

Fischer-Valuck BW, Chen I, Srivastava AJ, Floberg JM, Rao YJ, King AA, Shinohara ET, Perkins SM. Fischer-Valuck BW, et al. Among authors: king aa. Cancer. 2017 Feb 15;123(4):682-687. doi: 10.1002/cncr.30405. Epub 2016 Nov 2. Cancer. 2017. PMID: 27861763 Free article.

5

Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.

King AA, Noetzel M, White DA, McKinstry RC, Debaun MR. King AA, et al. Pediatr Blood Cancer. 2008 Mar;50(3):599-602. doi: 10.1002/pbc.21338. Pediatr Blood Cancer. 2008. PMID: 17985350 Clinical Trial.

6

Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.

Dean JB, Hayashi SS, Albert CM, King AA, Karzon R, Hayashi RJ. Dean JB, et al. Among authors: king aa. J Pediatr Hematol Oncol. 2008 Feb;30(2):130-4. doi: 10.1097/MPH.0b013e31815d1d83. J Pediatr Hematol Oncol. 2008. PMID: 18376265

7

Oligodendrogliomas in children.

Creach KM, Rubin JB, Leonard JR, Limbrick DD, Smyth MD, Dacey R, Rich KM, Dowling JL, Grubb RL Jr, Linette GP, King AA, Michalski JM, Park TS, Perry A, Simpson JR, Mansur DB. Creach KM, et al. Among authors: king aa. J Neurooncol. 2012 Jan;106(2):377-82. doi: 10.1007/s11060-011-0674-6. Epub 2011 Aug 13. J Neurooncol. 2012. PMID: 21842314

8

Prevalence of Developmental Delay and Contributing Factors Among Children With Sickle Cell Disease.

Drazen CH, Abel R, Gabir M, Farmer G, King AA. Drazen CH, et al. Among authors: king aa. Pediatr Blood Cancer. 2016 Mar;63(3):504-10. doi: 10.1002/pbc.25838. Epub 2015 Nov 17. Pediatr Blood Cancer. 2016. PMID: 26575319

9

Implementation of an educational intervention to optimize self-management and transition readiness in young adults with sickle cell disease.

Calhoun CL, Abel RA, Pham HA, Thompson S, King AA. Calhoun CL, et al. Among authors: king aa. Pediatr Blood Cancer. 2019 Jul;66(7):e27722. doi: 10.1002/pbc.27722. Epub 2019 Mar 25. Pediatr Blood Cancer. 2019. PMID: 30907500 Free PMC article.

10

Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.

Knisely MR, Pugh N, Kroner B, Masese R, Gordeuk V, King AA, Smith SM, Gurney JG, Adams R, Wun T, Snyder A, Glassberg J, Shah N, Treadwell M; Sickle Cell Disease Implementation Consortium. Knisely MR, et al. Among authors: king aa. Am J Hematol. 2020 Sep;95(9):1066-1074. doi: 10.1002/ajh.25880. Epub 2020 Jun 29. Am J Hematol. 2020. PMID: 32449965 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,037 results

Search Page